Breaking News

FDA APPROVES AQVESME™ (mitapivat) | First Oral Therapy for Anaemia Across All Forms of Thalassaemia
PUTTING PATIENTS FIRST IN CLINICAL RESEARCH | New EU Recommendations to Reduce Trials Bureaucracy
EU AGREES LANDMARK REFORM OF PHARMACEUTICAL LEGISLATION | What It Means for Patients and Public Health
1st TIF NURSING WORKSHOP ON HAEMOGLOBINOPATHIES | 29-30 November 2025
1st TIF NURSING WORKSHOP ON HAEMOGLOBINOPATHIES | 29-30 November 2025
TOPICS IN FOCUS SERIES | Guidelines for the Management of Thalassaemia Syndromes
ANNUAL REPORT 2024 | A Year of Resilience and Progress
SICKLE CELL DISEASE | Inflammation during Menstrual Cycle May Trigger Pain Crises
SEVERE APLASTIC ANAEMIA | Stem Cell Transplant Opens New Possibilities
BOOSTING DONOR HEALTH | How Iron Speeds Post-Donation Recovery

English

Menu

Home
Who we are
What we do
Haemoglobin Disorders
Positions & Policies
Publications
Media Centre
- News
- Newsletters
- Events
- Videos
Contact us

Search for

Home/Who we are/About TIF/Membership/Benefits for Associate Members

Benefits for Associate Members

More information coming soon.

Quick links

For Patients
For Healthcare Professionals
For Associations
For Supporters
TIF Members
Useful Links
Sitemap

Follow us

Facebook
X
LinkedIn
YouTube
Instagram
RSS

© Copyright 2026, All Rights Reserved |

Powered by Genestial

Transparency Statement | Privacy Policy

Back to top button

Close

Facebook
X
LinkedIn
YouTube
Instagram
RSS

Search for: